1. The subject of the order is the gradual delivery of pharmaceuticals as part of drug programs to the Team of Health Care Facilities in Cieszyn.

The order consists of 34 lots, each of which is a separate subject of the contract.

2. The full assortment divided into parts along with the expected demand is included in Annex 1 to the SWZ – Price form.

3. Deliveries will take place successively during the term of the contract based on written orders placed by the Employer's Hospital Pharmacy.

4. Conditions to which supplies must correspond are contained in point III. 3. SWZ.

5. Website address of the proceedings (link leading directly to the view of the proceedings on the e-Procurement Platform):

https://ezamowienia.gov.pl/mp-client/search/list/ocds-148610-8d44105b-a863-11ed-b8d9-2a18c1f2976f

6. Investigation ID: ocds-148610-8d44105b-a863-11ed-b8d9-2a18c1f2976f

The subject of the contract are successive deliveries of Ustekinumabum. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is the successive supply of Omalizumab. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is successive deliveries of Secukinumab. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract are successive deliveries of Guselcumabum. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is the successive supply of Lamivudine. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract are successive deliveries of Tenofovir. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is the successive supply of Entecavir. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is successive deliveries of Glecaprevir + pibrentasvir. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is the successive delivery of Elbasvir + grazoprevir. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is the successive delivery of Sofosbuvie + velpatasvir. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is the successive supply of Enzalutamide. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is the successive delivery of Adalimumabum. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract are successive deliveries of Interferonum beta - 1 a. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract are successive deliveries of glatiramer acetate. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract are successive deliveries of Fingolimod. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the order are successive deliveries of Interferon beta - 1 b. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is successive deliveries of Teriflunomide. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract are successive deliveries of dimethyl fumarate. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract are successive deliveries of Natalizumab. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is the successive deliveries of Cladrybin. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is the successive supply of Ocrelizumab. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract are successive deliveries of Tolvaptanum. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is the successive supply of Iksekizumab. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the order are successive deliveries of Botulinum Toxin A. Full description, size, scope, type and quantity have been specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the order are successive deliveries of Botulinum Toxin A. Full description, size, scope, type and quantity have been specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the order are successive deliveries of Botulinum Toxin A. Full description, size, scope, type and quantity have been specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the order are successive deliveries of Botulinum Toxin A. Full description, size, scope, type and quantity have been specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract are successive deliveries of Human Immumoglobulin. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract are successive deliveries of Infliximabum. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is successive deliveries of Baricitinib. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is the successive supply of Upadacytinib. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is successive deliveries of Tyldrakizumab. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is successive deliveries of Dupilumab. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is successive deliveries of Risankizumab. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 1 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.